Top Upgrades
- JP Morgan upgraded Verizon Communications Inc. VZ from Neutral to Overweight. Verizon shares rose 0.97 percent to $47.65 in pre-market trading.
- Barclays upgraded Sarepta Therapeutics, Inc. SRPT from Equal-Weight to Overweight. Sarepta Therapeutics shares rose 1.86 percent to $92.00 in pre-market trading.
- Nomura upgraded Semiconductor Manufacturing International Corporation SMI from Reduce to Neutral. Semiconductor Manufacturing shares fell 3.31 percent to $7.00 in pre-market trading.
- Bernstein upgraded Baidu, Inc. BIDU from Underperform to Market Perform. Baidu shares rose 0.86 percent to $271.00 in pre-market trading.
- Wedbush upgraded Voyager Therapeutics, Inc. VYGR from Neutral to Outperform. Voyager Therapeutics shares gained 4.42 percent to $17.50 in pre-market trading.
- Analysts at SunTrust Robinson Humphrey upgraded Great Plains Energy Incorporated GXP from Hold to Buy. Great Plains Energy shares rose 0.84 percent to close at $32.23 on Thursday.
- Barclays upgraded Ultragenyx Pharmaceutical Inc. RARE from Equal-Weight to Overweight. Ultragenyx Pharmaceutical shares rose 0.61 percent to close at $59.76 on Thursday.
- Cowen & Co. upgraded Switch, Inc. SWCH from Underperform to Market Perform. Switch shares rose 3.57 percent to $15.95 in pre-market trading.
- RBC Capital upgraded The Mosaic Company MOS from Sector Perform to Outperform. Mosaic shares rose 1.52 percent to $26.77 in pre-market trading.
- Credit Suisse upgraded Mercer International Inc. MERC from Neutral to Outperform. Mercer shares rose 1.39 percent to close at $14.55 on Thursday.
Top Downgrades
- Macquarie downgraded Symantec Corporation SYMC from Outperform to Neutral. Symantec shares dropped 26.32 percent to $21.50 in pre-market trading.
- Credit Suisse downgraded Kohl's Corporation KSS from Outperform to Neutral. Kohl's shares fell 1.70 percent to $59.50 in pre-market trading.
- BTIG Research downgraded Q2 Holdings, Inc. QTWO from Buy to Neutral. Q2 Holdings shares rose 2.54 percent to close at $58.45 on Thursday.
- RBC Capital downgraded Presidio, Inc. PSDO from Outperform to Sector Perform. Presidio shares rose 1.71 percent to close at $15.45 on Thursday.
- Barclays downgraded Halozyme Therapeutics, Inc. HALO from Equal-Weight to Underweight. Halozyme Therapeutics shares fell 8.61 percent to $18.25 in pre-market trading.
- Deutsche Bank downgraded Coty Inc. COTY from Buy to Hold. Coty shares fell 2.07 percent to $14.20 in pre-market trading.
- Wells Fargo downgraded Choice Hotels International, Inc. CHH from Outperform to Market Perform. Choice Hotels shares fell 0.18 percent to close at $83.20 on Thursday.
- BMO Capital downgraded ARMO BioSciences, Inc. ARMO from Outperform to Market Perform. ARMO BioSciences shares rose 0.26 percent to $49.93 in pre-market trading.
- Baird downgraded Triumph Group, Inc. TGI from Outperform to Neutral. Triumph shares fell 8.52 percent to close at $22.55 on Thursday.
Top Initiations
- Analysts at Wedbush initiated coverage on Abercrombie & Fitch Co. ANF with a Neutral rating. The price target for Abercrombie & Fitch is set to $25. Abercrombie & Fitch shares closed at $26.12 on Thursday.
- H.C. Wainwright initiated coverage on Riot Blockchain, Inc. RIOT with a Buy rating. The price target for Riot Blockchain is set to $9. Riot Blockchain shares closed at $7.23 on Thursday.
- Analysts at Stephens & Co. initiated coverage on TriCo Bancshares TCBK with an Overweight rating. The price target for TriCo Bancshares is set to $43. TriCo Bancshares shares closed at $37.32 on Thursday.
- Needham initiated coverage on Euronet Worldwide, Inc. EEFT with a Buy rating. The price target for Euronet Worldwide is set to $100. Euronet Worldwide shares closed at $83.70 on Thursday.
- Wedbush initiated coverage on Lululemon Athletica Inc. LULU with a Neutral rating. The price target for Lululemon is set to $90. Lululemon shares closed at $97.91 on Thursday.
- BMO Capital initiated coverage on Cision Ltd. CISN with an Outperform rating. The price target for Cision is set to $16. Cision shares closed at $13.48 on Thursday.
- H.C. Wainwright initiated coverage on Spero Therapeutics, Inc. SPRO with a Buy rating. The price target for Spero Therapeutics is set to $28. Spero Therapeutics shares closed at $11.59 on Thursday.
- Wedbush initiated coverage on American Eagle Outfitters, Inc. AEO with an Outperform rating. The price target for American Eagle is set to $25. American Eagle shares closed at $20.11 on Thursday.
ANFAbercrombie & Fitch Co
$151.56-0.37%
BIDUBaidu Inc
$81.40-1.46%
CHHChoice Hotels International Inc
$140.420.13%
COTYCoty Inc
$6.81-2.01%
EEFTEuronet Worldwide Inc
$99.90-0.12%
HALOHalozyme Therapeutics Inc
$54.506.47%
KSSKohl's Corp
$13.50-2.32%
LULULululemon Athletica Inc
$392.60-0.22%
MERCMercer International Inc
$6.510.15%
MOSThe Mosaic Co
$24.72-2.10%
QTWOQ2 Holdings Inc
$100.001.48%
RAREUltragenyx Pharmaceutical Inc
$43.65-1.78%
RIOTRiot Platforms Inc
$12.03-3.06%
SMIVanEck HIP Sustainable Muni ETF
$45.78-0.39%
SPROSpero Therapeutics Inc
$1.00-4.75%
SRPTSarepta Therapeutics Inc
$126.501.61%
TCBKTriCo Bancshares
$42.22-%
TGITriumph Group Inc
$18.63-0.53%
VYGRVoyager Therapeutics Inc
$5.73-3.21%
VZVerizon Communications Inc
$39.110.49%
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Posted In:
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in